Lyell Immunopharma (LYEL) Other Operating Expenses (2020 - 2026)

Lyell Immunopharma's Other Operating Expenses history runs 7 years deep, the most recent figure standing at $1.9 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 1493.28% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $3.9 million (up 67.75% YoY), while the FY2025 annual figure was $2.1 million, down 35.18% from the prior year.
• Other Operating Expenses came in at $1.9 million for Q1 2026 at Lyell Immunopharma, up from $1.5 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $1.9 million in Q1 2026 to a low of -$1.1 million in Q2 2025.
• A 5-year average of $876117.6 and a median of $1.1 million in 2024 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses sank 208.81% in 2025 and jumped 1493.28% in 2026, its largest moves.
• Lyell Immunopharma's Other Operating Expenses stood at $1.2 million in 2022, then plunged by 47.02% to $641000.0 in 2023, then declined by 19.97% to $513000.0 in 2024, then jumped by 191.81% to $1.5 million in 2025, then advanced by 26.65% to $1.9 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $1.9 million, $1.5 million, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison